Healthcare conglomerate IHH Healthcare has announced the resignation of its Managing Director, Dr Kelvin Loh Chi-Keon with immediate effect.
The Singaporean was appointed the Chief Executive Officer and Executive Director of IHH Healthcare Berhad on 1 July 2019 and assumed the position of Managing Director and CEO of IHH with effect from 1 January 2020. He also serves on the Boards and Board Committees of IHH subsidiaries. Dr Loh started his career as a practising physician and then spent a decade in the public sector in Singapore in areas such as clinical services development, hospital planning and hospital operations.
Dr Loh first joined IHH Group in 2008. Between 2008 and 2017, he held a number of senior management roles before taking over as the CEO for its Singapore Operations Division (now known as IHH Healthcare Singapore), covering among other services, the four multi-specialty tertiary hospitals a Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East. In 2017, Dr Loh moved to Columbia Asia Group as CEO where he was responsible for overseeing its 28 hospitals across four countries in Asia. He rejoined IHH in July 2019.
Dr Loh’s interest as at 22 February 2023 is as follows: Direct interest in a subsidiary: Parkway Life Real Estate Investment Trust – 120,000 units
